Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Ingelheim (China) Investment Co. Ltd.

Division of Boehringer Ingelheim International GmbH
www.boehringer-ingelheim.com.cn

Latest From Boehringer Ingelheim (China) Investment Co. Ltd.

Asia Executives To Watch: Aslan, CanBridge, Sosei, Wuxi NextCode

The New Year brings in new executive moves including a new China GM for ASLAN a new CMO for Sosei, while CanBridge and WuXi NextCode have appointed new VPs.

Appointments Asia Pacific

BeiGene Bags $750m, Sees China Reforms Creating New Opportunities

A spectacular secondary offering will enable Beijing-based BeiGene to expand in both novel R&D and manufacturing in 2018, driven largely by an integrated China-global approach, its CFO says.

ImmunoOncology Financing
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register